1. Home
  2. UK vs GOVX Comparison

UK vs GOVX Comparison

Compare UK & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ucommune International Ltd

UK

Ucommune International Ltd

N/A

Current Price

$0.47

Market Cap

3.5M

ML Signal

N/A

Logo GeoVax Labs Inc.

GOVX

GeoVax Labs Inc.

N/A

Current Price

$1.49

Market Cap

4.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UK
GOVX
Founded
2015
2001
Country
China
United States
Employees
127
17
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5M
4.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
UK
GOVX
Price
$0.47
$1.49
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$200.00
AVG Volume (30 Days)
27.1K
61.7K
Earning Date
04-28-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.42
$0.12
52 Week High
$1.21
$4.40

Technical Indicators

Market Signals
Indicator
UK
GOVX
Relative Strength Index (RSI) 41.13 40.53
Support Level N/A $1.49
Resistance Level $1.05 $4.40
Average True Range (ATR) 0.05 0.17
MACD -0.00 -0.02
Stochastic Oscillator 18.64 29.85

Price Performance

Historical Comparison
UK
GOVX

About UK Ucommune International Ltd

Ucommune International Ltd is a flexible office space provider and manager based in the People's Republic of China (PRC). The company offers long-term leasing, on-demand, and short-term leasing solutions to freelancers, start-up entrepreneurs, small and medium enterprises, and corporations. Company provide fully-serviced and well-furnished office spaces on a flexible basis. The members of the Ucommune community, which includes individuals and enterprises registered on the U bazaar mobile app, can avail of these services. The company has three operating segments: Workspace membership, Marketing and branding services, and Other services. Marketing and branding services generate the majority of the company's revenue.

About GOVX GeoVax Labs Inc.

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.

Share on Social Networks: